Heart Failure With Preserved Ejection Fraction Hfpef clinical trials

Explore recruiting heart failure with preserved ejection fraction hfpef clinical trials.

Recruiting heart failure with preserved ejection fraction hfpef studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Heart Failure With Preserved Ejection Fraction Hfpef trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2A, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986435/MYK-224 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

Spain, Poland, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

J3E-MC-EZDB: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction (HFpEF)

Hungary, Poland, Spain, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

A Study to Learn About the Study Medicine Called PF-07293893 in Healthy Adults, and How Different Doses of Study Medicine are Tolerated and Act in the Body.

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

The Colchicine heart failure preserved trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF)

Italy, Germany, France, Sweden, Belgium, Poland +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo-Controlled for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF)

Belgium, Germany, Italy, Sweden, Spain, France +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Heart Failure With Preserved Ejection Fraction Hfpef trials by city

Heart Failure With Preserved Ejection Fraction Hfpef in Toronto Heart Failure With Preserved Ejection Fraction Hfpef in Vancouver Heart Failure With Preserved Ejection Fraction Hfpef in Montreal Heart Failure With Preserved Ejection Fraction Hfpef in Calgary Heart Failure With Preserved Ejection Fraction Hfpef in Edmonton Heart Failure With Preserved Ejection Fraction Hfpef in Ottawa Heart Failure With Preserved Ejection Fraction Hfpef in Winnipeg Heart Failure With Preserved Ejection Fraction Hfpef in Quebec City Heart Failure With Preserved Ejection Fraction Hfpef in Hamilton Heart Failure With Preserved Ejection Fraction Hfpef in Kitchener Heart Failure With Preserved Ejection Fraction Hfpef in London Heart Failure With Preserved Ejection Fraction Hfpef in Halifax Heart Failure With Preserved Ejection Fraction Hfpef in New York Heart Failure With Preserved Ejection Fraction Hfpef in Los Angeles Heart Failure With Preserved Ejection Fraction Hfpef in Chicago Heart Failure With Preserved Ejection Fraction Hfpef in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease